Latest News

Flaw in Alzheimer's drug trial test, research suggests

New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Newer contraceptive pills linked to higher clot risks, study confirms

  • Psychedelic drugs should be legally reclassified as they may benefit patients, experts say

  • Toddler temperament could be influenced by different types of gut bacteria

  • Access to mental health care for teens improving, but less for communities with disparities

  • Are antidepressants more effective than usually assumed?

  • Flood aftermath linked to post-traumatic stress, study shows

  • Strength-based parenting improves children's resilience and stress levels

  • New evidence confirms link between newer contraceptive pills and higher clot risks

  • Psychedelic drugs should be legally reclassified as they may benefit patients

  • Cocaine addiction, craving and relapse

  •